array(40) {
  [0]=>
  string(4) "2381"
  ["article_id"]=>
  string(4) "2381"
  [1]=>
  string(61) "First Medical Device to Treat ADHD in Children Gets FDA OK"
  ["article_title"]=>
  string(61) "First Medical Device to Treat ADHD in Children Gets FDA OK"
  [2]=>
  string(153) "The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.&#nlThe post First Medical Device to Treat ADHD in Ch"
  ["short_description"]=>
  string(153) "The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.&#nlThe post First Medical Device to Treat ADHD in Ch"
  [3]=>
  string(469) "
The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.
&#nl
The post First Medical Device to Treat ADHD in Children Gets FDA OK appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(469) "
The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.
&#nl
The post First Medical Device to Treat ADHD in Children Gets FDA OK appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(108) "https://www.medtechintelligence.com/news_article/first-medical-device-to-treat-adhd-in-children-gets-fda-ok/"
  ["blog_url"]=>
  string(108) "https://www.medtechintelligence.com/news_article/first-medical-device-to-treat-adhd-in-children-gets-fda-ok/"
  [15]=>
  string(19) "2019-04-23 02:21:37"
  ["add_date"]=>
  string(19) "2019-04-23 02:21:37"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:22"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:22"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1864"
  ["article_id"]=>
  string(4) "1864"
  [1]=>
  string(59) "First Medical Device to Treat ADHD in Children Gets FDA OK"
  ["article_title"]=>
  string(59) "First Medical Device to Treat ADHD in Children Gets FDA OK"
  [2]=>
  string(153) "The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.&#nlThe post First Medical Device to Treat ADHD in Ch"
  ["short_description"]=>
  string(153) "The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.&#nlThe post First Medical Device to Treat ADHD in Ch"
  [3]=>
  string(469) "
The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.
&#nl
The post First Medical Device to Treat ADHD in Children Gets FDA OK appeared first on MedTech Intelligence.
&#nl"
  ["description"]=>
  string(469) "
The non-invasive trigeminal nerve stimulation system is intended for patients seven to 12 years old.
&#nl
The post First Medical Device to Treat ADHD in Children Gets FDA OK appeared first on MedTech Intelligence.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "98"
  ["rss_id"]=>
  string(2) "98"
  [14]=>
  string(108) "https://www.medtechintelligence.com/news_article/first-medical-device-to-treat-adhd-in-children-gets-fda-ok/"
  ["blog_url"]=>
  string(108) "https://www.medtechintelligence.com/news_article/first-medical-device-to-treat-adhd-in-children-gets-fda-ok/"
  [15]=>
  string(19) "2019-04-23 02:21:37"
  ["add_date"]=>
  string(19) "2019-04-23 02:21:37"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-04-29 16:09:30"
  ["create_at"]=>
  string(19) "2019-04-29 16:09:30"
  [19]=>
  string(59) "First_Medical_Device_to_Treat_ADHD_in_Children_Gets_FDA__OK"
  ["slug"]=>
  string(59) "First_Medical_Device_to_Treat_ADHD_in_Children_Gets_FDA__OK"
}
                    

array(40) {
  [0]=>
  string(4) "2415"
  ["article_id"]=>
  string(4) "2415"
  [1]=>
  string(38) "GMOs Have Benefits for the Environment"
  ["article_title"]=>
  string(38) "GMOs Have Benefits for the Environment"
  [2]=>
  string(104) "The measles resurgence has vaccines back in the headlines this Earth Day, but there’s another ..."
  ["short_description"]=>
  string(104) "The measles resurgence has vaccines back in the headlines this Earth Day, but there’s another ..."
  [3]=>
  string(849) "The measles resurgence has vaccines back in the headlines this Earth Day, but there’s another ..."
  ["description"]=>
  string(849) "The measles resurgence has vaccines back in the headlines this Earth Day, but there’s another ..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "102"
  ["rss_id"]=>
  string(3) "102"
  [14]=>
  string(95) "http://feedproxy.google.com/~r/BiotechNow/~3/nDBsVEetAj4/gmos-have-benefits-for-the-environment"
  ["blog_url"]=>
  string(95) "http://feedproxy.google.com/~r/BiotechNow/~3/nDBsVEetAj4/gmos-have-benefits-for-the-environment"
  [15]=>
  string(19) "2019-04-22 22:00:06"
  ["add_date"]=>
  string(19) "2019-04-22 22:00:06"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:32"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2176"
  ["article_id"]=>
  string(4) "2176"
  [1]=>
  string(57) "Extrusion: Why this is important for catheter development"
  ["article_title"]=>
  string(57) "Extrusion: Why this is important for catheter development"
  [2]=>
  string(102) "Vistamed, part of Freudenberg Medical, highlights the importance of extrusion in catheter development."
  ["short_description"]=>
  string(102) "Vistamed, part of Freudenberg Medical, highlights the importance of extrusion in catheter development."
  [3]=>
  string(102) "Vistamed, part of Freudenberg Medical, highlights the importance of extrusion in catheter development."
  ["description"]=>
  string(102) "Vistamed, part of Freudenberg Medical, highlights the importance of extrusion in catheter development."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(55) "https://www.medicalplasticsnews.com/news/balancing-act/"
  ["blog_url"]=>
  string(55) "https://www.medicalplasticsnews.com/news/balancing-act/"
  [15]=>
  string(19) "2019-04-20 18:00:00"
  ["add_date"]=>
  string(19) "2019-04-20 18:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2177"
  ["article_id"]=>
  string(4) "2177"
  [1]=>
  string(87) "How Compounding Solutions' technologies can address the needs of the medtech sector"
  ["article_title"]=>
  string(87) "How Compounding Solutions' technologies can address the needs of the medtech sector"
  [2]=>
  string(150) "Compounding Solutions, a specialist in medical extrusions, highlights technologies such as ReZilok which it believes address some of the current needs"
  ["short_description"]=>
  string(150) "Compounding Solutions, a specialist in medical extrusions, highlights technologies such as ReZilok which it believes address some of the current needs"
  [3]=>
  string(173) "Compounding Solutions, a specialist in medical extrusions, highlights technologies such as ReZilok which it believes address some of the current needs of the medtech sector."
  ["description"]=>
  string(173) "Compounding Solutions, a specialist in medical extrusions, highlights technologies such as ReZilok which it believes address some of the current needs of the medtech sector."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(72) "https://www.medicalplasticsnews.com/news/how-compounding-solutions-tech/"
  ["blog_url"]=>
  string(72) "https://www.medicalplasticsnews.com/news/how-compounding-solutions-tech/"
  [15]=>
  string(19) "2019-04-19 17:00:00"
  ["add_date"]=>
  string(19) "2019-04-19 17:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "5298"
  ["article_id"]=>
  string(4) "5298"
  [1]=>
  string(51) "4th World Conference on Breast and Cervical Cancer "
  ["article_title"]=>
  string(51) "4th World Conference on Breast and Cervical Cancer "
  [2]=>
  string(150) "Breast and Cervical cancer Conference welcomes you to grace with your presence. 4th World Conference on Breast and Cervical Cancer to be held in  Amst"
  ["short_description"]=>
  string(150) "Breast and Cervical cancer Conference welcomes you to grace with your presence. 4th World Conference on Breast and Cervical Cancer to be held in  Amst"
  [3]=>
  string(500) "Breast and Cervical cancer Conference welcomes you to grace with your presence. 4th World Conference on Breast and Cervical Cancer to be held in  Amsterdam, Netherlands during November 14-15, 2019. This 4th Breast and Cervical Cancer conference will bring together cancer researchers, oncologists, professors, and scientists to discuss strategies for Breast and Cervical Cancer globally. BreCeCan 2019 is designed to provide divergent and prevailing education that will gather Oncology professiona..."
  ["description"]=>
  string(500) "Breast and Cervical cancer Conference welcomes you to grace with your presence. 4th World Conference on Breast and Cervical Cancer to be held in  Amsterdam, Netherlands during November 14-15, 2019. This 4th Breast and Cervical Cancer conference will bring together cancer researchers, oncologists, professors, and scientists to discuss strategies for Breast and Cervical Cancer globally. BreCeCan 2019 is designed to provide divergent and prevailing education that will gather Oncology professiona..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "3"
  ["category"]=>
  string(1) "3"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "58"
  ["rss_id"]=>
  string(2) "58"
  [14]=>
  string(82) "https://www.pharmiweb.com/event/4th-world-conference-on-breast-and-cervical-cancer"
  ["blog_url"]=>
  string(82) "https://www.pharmiweb.com/event/4th-world-conference-on-breast-and-cervical-cancer"
  [15]=>
  string(19) "2019-04-19 13:42:28"
  ["add_date"]=>
  string(19) "2019-04-19 13:42:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-10-31 15:50:28"
  ["create_at"]=>
  string(19) "2019-10-31 15:50:28"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1913"
  ["article_id"]=>
  string(4) "1913"
  [1]=>
  string(60) "FDA Updates on Angiotensin II Receptor Blocker (ARB) Recalls"
  ["article_title"]=>
  string(60) "FDA Updates on Angiotensin II Receptor Blocker (ARB) Recalls"
  [2]=>
  string(158) "Audience: Consumer, Health Professional, Pharmacy Investigation ongoing – This page to be updated as more information is available&#nlIMPORTANT: Medica"
  ["short_description"]=>
  string(158) "Audience: Consumer, Health Professional, Pharmacy Investigation ongoing – This page to be updated as more information is available&#nlIMPORTANT: Medica"
  [3]=>
  string(247) "Audience: Consumer, Health Professional, Pharmacy Investigation ongoing – This page to be updated as more information is available&#nlIMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled...."
  ["description"]=>
  string(247) "Audience: Consumer, Health Professional, Pharmacy Investigation ongoing – This page to be updated as more information is available&#nlIMPORTANT: Medications containing only amlodipine or hydrochlorothiazide (HCTZ) are not being recalled...."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(200) "https://www.drugs.com/fda/fda-updates-angiotensin-ii-receptor-blocker-arb-recalls-14201.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Updates+on+Angiotensin+II+Receptor+Blocker+%28ARB%29+Recalls"
  ["blog_url"]=>
  string(200) "https://www.drugs.com/fda/fda-updates-angiotensin-ii-receptor-blocker-arb-recalls-14201.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Updates+on+Angiotensin+II+Receptor+Blocker+%28ARB%29+Recalls"
  [15]=>
  string(19) "2019-04-19 08:00:00"
  ["add_date"]=>
  string(19) "2019-04-19 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1912"
  ["article_id"]=>
  string(4) "1912"
  [1]=>
  string(105) "Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling"
  ["article_title"]=>
  string(105) "Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product Mislabeling"
  [2]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy April 19, 2019 -- Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 "
  ["short_description"]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy April 19, 2019 -- Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 "
  [3]=>
  string(244) "Audience: Consumer, Health Professional, Pharmacy April 19, 2019 -- Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h..."
  ["description"]=>
  string(244) "Audience: Consumer, Health Professional, Pharmacy April 19, 2019 -- Alvogen, Inc. is voluntarily recalling two lots of Fentanyl Transdermal System 12 mcg/h transdermal patches to the consumer level. A small number of cartons labeled 12 mcg/h..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(277) "https://www.drugs.com/fda/alvogen-inc-issues-voluntary-nationwide-recall-fentanyl-transdermal-due-product-mislabeling-14263.html?utm_source=ddc&utm_medium=rss&utm_campaign=Alvogen+Inc.+Issues+Voluntary+Nationwide+Recall+of+Fentanyl+Transdermal+System+Due+to+Product+Mislabeling"
  ["blog_url"]=>
  string(277) "https://www.drugs.com/fda/alvogen-inc-issues-voluntary-nationwide-recall-fentanyl-transdermal-due-product-mislabeling-14263.html?utm_source=ddc&utm_medium=rss&utm_campaign=Alvogen+Inc.+Issues+Voluntary+Nationwide+Recall+of+Fentanyl+Transdermal+System+Due+to+Product+Mislabeling"
  [15]=>
  string(19) "2019-04-19 08:00:00"
  ["add_date"]=>
  string(19) "2019-04-19 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1992"
  ["article_id"]=>
  string(4) "1992"
  [1]=>
  string(117) " Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis"
  ["article_title"]=>
  string(117) " Pfizer and Lilly Announce Top-Line Results From Long-Term Phase 3 Study of Tanezumab in Patients With Osteoarthritis"
  [2]=>
  string(150) "NEW YORK & INDIANAPOLIS--(BUSINESS WIRE) April 18, 2019 -- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line re"
  ["short_description"]=>
  string(150) "NEW YORK & INDIANAPOLIS--(BUSINESS WIRE) April 18, 2019 -- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line re"
  [3]=>
  string(251) "NEW YORK & INDIANAPOLIS--(BUSINESS WIRE) April 18, 2019 -- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study was to..."
  ["description"]=>
  string(251) "NEW YORK & INDIANAPOLIS--(BUSINESS WIRE) April 18, 2019 -- Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced top-line results from a Phase 3 study evaluating tanezumab 2.5 mg and 5 mg. The objective of the study was to..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(300) "https://www.drugs.com/clinical_trials/pfizer-lilly-announce-top-line-results-long-term-phase-3-study-tanezumab-patients-osteoarthritis-18128.html?utm_source=ddc&utm_medium=rss&utm_campaign=+Pfizer+and+Lilly+Announce+Top-Line+Results+From+Long-Term+Phase+3+Study+of+Tanezumab+in+Patients+With+Osteoart"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/clinical_trials/pfizer-lilly-announce-top-line-results-long-term-phase-3-study-tanezumab-patients-osteoarthritis-18128.html?utm_source=ddc&utm_medium=rss&utm_campaign=+Pfizer+and+Lilly+Announce+Top-Line+Results+From+Long-Term+Phase+3+Study+of+Tanezumab+in+Patients+With+Osteoart"
  [15]=>
  string(19) "2019-04-19 06:04:08"
  ["add_date"]=>
  string(19) "2019-04-19 06:04:08"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:57"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2124"
  ["article_id"]=>
  string(4) "2124"
  [1]=>
  string(71) "Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator"
  ["article_title"]=>
  string(71) "Redox Wrangles $33M to Become Healthcare’s Go-To Data Integrator"
  [2]=>
  string(150) "[Updated 5/3/19, 12:55 pm CT. See below.] As hospitals and clinics have shifted from paper-based records to digital systems, one of the biggest challe"
  ["short_description"]=>
  string(150) "[Updated 5/3/19, 12:55 pm CT. See below.] As hospitals and clinics have shifted from paper-based records to digital systems, one of the biggest challe"
  [3]=>
  string(403) "[Updated 5/3/19, 12:55 pm CT. See below.] As hospitals and clinics have shifted from paper-based records to digital systems, one of the biggest challenges has been sharing patient data between healthcare providers, and between providers and outside software applications. This “interoperability” problem has created a market for companies such as Redox, a Madison, WI-based startup […]"
  ["description"]=>
  string(403) "[Updated 5/3/19, 12:55 pm CT. See below.] As hospitals and clinics have shifted from paper-based records to digital systems, one of the biggest challenges has been sharing patient data between healthcare providers, and between providers and outside software applications. This “interoperability” problem has created a market for companies such as Redox, a Madison, WI-based startup […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "37"
  ["rss_id"]=>
  string(2) "37"
  [14]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/Bh4VR01D4Nk/"
  ["blog_url"]=>
  string(62) "http://feedproxy.google.com/~r/XconomyHealthIT/~3/Bh4VR01D4Nk/"
  [15]=>
  string(19) "2019-04-18 20:56:14"
  ["add_date"]=>
  string(19) "2019-04-18 20:56:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2178"
  ["article_id"]=>
  string(4) "2178"
  [1]=>
  string(60) "DuPont launches new enzyme portfolio for instrument cleaning"
  ["article_title"]=>
  string(60) "DuPont launches new enzyme portfolio for instrument cleaning"
  [2]=>
  string(150) "DuPont Nutrition & Biosciences has announced the launch of its Optimase portfolio of biobased enzymes for medical instrument cleaning applications"
  ["short_description"]=>
  string(150) "DuPont Nutrition & Biosciences has announced the launch of its Optimase portfolio of biobased enzymes for medical instrument cleaning applications"
  [3]=>
  string(151) "DuPont Nutrition & Biosciences has announced the launch of its Optimase portfolio of biobased enzymes for medical instrument cleaning applications."
  ["description"]=>
  string(151) "DuPont Nutrition & Biosciences has announced the launch of its Optimase portfolio of biobased enzymes for medical instrument cleaning applications."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/dupont-launches-new-enzyme-portfolio-for-instrument-cleaning/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/dupont-launches-new-enzyme-portfolio-for-instrument-cleaning/"
  [15]=>
  string(19) "2019-04-18 18:39:00"
  ["add_date"]=>
  string(19) "2019-04-18 18:39:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "2179"
  ["article_id"]=>
  string(4) "2179"
  [1]=>
  string(79) "NICE's new META tool module to be evaluated at the Med-Tech Innovation Expo"
  ["article_title"]=>
  string(79) "NICE's new META tool module to be evaluated at the Med-Tech Innovation Expo"
  [2]=>
  string(150) "Jeanette Kusel, director for NICE scientific advice discusses the launch of a new module of the META tool and the changing face of the digital health "
  ["short_description"]=>
  string(150) "Jeanette Kusel, director for NICE scientific advice discusses the launch of a new module of the META tool and the changing face of the digital health "
  [3]=>
  string(181) "Jeanette Kusel, director for NICE scientific advice discusses the launch of a new module of the META tool and the changing face of the digital health technology landscape in the UK."
  ["description"]=>
  string(181) "Jeanette Kusel, director for NICE scientific advice discusses the launch of a new module of the META tool and the changing face of the digital health technology landscape in the UK."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(61) "https://www.medicalplasticsnews.com/news/NICEs-new-META-tool/"
  ["blog_url"]=>
  string(61) "https://www.medicalplasticsnews.com/news/NICEs-new-META-tool/"
  [15]=>
  string(19) "2019-04-18 17:00:00"
  ["add_date"]=>
  string(19) "2019-04-18 17:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:40"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}